TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Por Song Min, Jin JingJi, Lim Jeong-Eun, Kou Jinghong, Pattanayak Abhinandan, Rehman Jamaal A, Kim Hong-Duck, Tahara Kazuki, Lalonde Robert, Fukuchi Ken-ichiro
Publicado em 2011-08-01

TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Por Song, Min, Jin, JingJi, Lim, Jeong-Eun, Kou, Jinghong, Pattanayak, Abhinandan, Rehman, Jamaal A, Kim, Hong-Duck, Tahara, Kazuki, Lalonde, Robert, Fukuchi, Ken-ichiro
Publicado em 2011

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer (NSCLC)

Por McLaughlin, Joseph, Han, Gang, Schalper, Kurt A., Carvajal-Hausdorf, Daniel, Pelakanou, Vasiliki, Rehman, Jamaal, Velcheti, Vamsidhar, Herbst, Roy, LoRusso, Patricia, Rimm, David L.
Publicado no JAMA Oncol (2016)

Quantitative and Pathologist-Read comparison of the Heterogeneity of Programmed Death-Ligand 1(PD-L1) expression in Non-Small Cell Lung Cancer

Por Rehman, Jamaal A., Han, Gang, Carvajal-Hausdorf, Daniel E., Wasserman, Brad E., Pelekanou, Vasiliki, Mani, Nikita L., McLaughlin, Joseph, Schalper, Kurt A., Rimm, David L.
Publicado no Mod Pathol (2016)

Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Por Smithy, James W., Moore, Lauren M., Pelekanou, Vasiliki, Rehman, Jamaal, Gaule, Patricia, Wong, Pok Fai, Neumeister, Veronique M., Sznol, Mario, Kluger, Harriet M., Rimm, David L.
Publicado no J Immunother Cancer (2017)